Denali Announces Rolling Regulatory Submission of Tividenofusp Alfa for Hunter Syndrome
CGRP Therapies as Potential First-Line Migraine Preventive Treatment: Andrew Charles, MD
Aggressive Blood Pressure Lowering for Intracerebral Hemorrhage Management: Chitra Venkatasubramanian, MBBS, MD, MSc, FNCS
Fremanezumab Aims to Become First CGRP-Targeting Migraine Preventive for Pediatric and Adults Following sBLA Acceptance